Friday, 6 January 2017

Regeneron Is Down, Not Out

Biotech stock Regeneron should recover from a surprise injunction over a new cholesterol drug.

from WSJ.com: Markets http://ift.tt/2iK4Br2
via https://ifttt.com/ IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)